Notice is given that the Annual General Meeting of Nordic Nanovector ASA will be
held on 28 June 2023, at 14:00 hours CEST at Advokatfirmaet CLP, Sommerrogata 13
-15, 0255 Oslo. The full notice is attached. The notice and the documents to
which it refers are also available on
(http://www.nordicnanovector.com)www.nordicnanovector.com.
Shareholders wishing to attend the Annual General Meeting, in person or by
proxy, must complete and return the attendance form or power of attorney form
attached to the notice to Nordea Bank Abp, Issuer Service, Postboks 1166
Sentrum, N-0107 Oslo, or by e-mail to nis@nordea.com no later than 26 June 2023,
16:00 CEST. Attendance or proxies may also be registered electronically through
Euronext Securities Oslo (formerly VPS) Investor Services.
For further information, please contact:
IR enquiries
Ludvik Sandnes, Interim CEO & CFO
Cell: +47907 43 017
Email:ir@nordicnanovector.com
About Nordic Nanovector:
Nordic Nanovector is committed to develop and deliver innovative therapies to
patients to address major unmet medical needs and advance cancer care. Further
information can be found
atwww.nordicnanovector.com (https://nam10.safelinks.protection.outlook.com/?url=
h
ttp%3A%2F%2Fwww.nordicnanovector.com%2F&data=04%7C01%7CMark.Swallow%40medistrava
.
com%7Cbd8fdb7f05284d3963a108d9d20ae447%7C5c24475f929349d0b4e1ba6d190e92f9%7C0%7C
0
%7C637771766496096573%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMz
I
iLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=xp8WBxqCMdEa4qM%2FjJAyw9bnfalGpQqsw
X
zSzRJqqWo%3D&reserved=0).